Showing results (461-470 of 843) with videos related to
Sort By:
Pageof 85
Liver International : Official Journal of the International Association for the Study of the Liver|March 16, 2013
Normal enhanced liver fibrosis (ELF) values in apparently healthy subjects undergoing a health check-up and in living liver donors in South KoreaEun Jin Yoo, Beom Kyung Kim, Seung Up Kim, et al.BMC Cancer|January 4, 2013
Prognostic value of α-fetoprotein and des-γ-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolizationYong Kang Lee, Seung Up Kim, Do Young Kim, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 26, 2020
Impact of antiviral therapy on risk prediction model for hepatocellular carcinoma development in patients with chronic hepatitis BHye Yeon Chon, Jae Seung Lee, Hye Won Lee, et al.Journal of Clinical Gastroenterology|June 13, 2012
The accuracy of noninvasive methods in predicting the development of hepatocellular carcinoma and hepatic decompensation in patients with chronic hepatitis BYoung Eun Chon, Eun Suk Jung, Jun Yong Park, et al.Journal of Infection and Public Health|December 10, 2025
Implementation of an alert system for the care cascade of Hepatitis C infection in patients undergoing elective surgeryJae Seung Lee, Ho Soo Chun, Hye Won Lee, et al.Animal Cells and Systems|October 15, 2025
LncRNA-mRNA integrated networks in the neuroendocrine system of bisphenol a-treated mice induce cellular dysfunctions by disrupting transcriptional homeostasisSeung-Mi Oh, Byeonghwi Lim, Yoon-Been Park, et al.Plos One|October 11, 2012
Performance of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B: a meta-analysisYoung Eun Chon, Eun Hee Choi, Ki Jun Song, et al.Cancers|November 21, 2020
Hepatocellular Carcinoma Risk According to Regimens for Eradication of Hepatitis C Virus; Interferon or Direct Acting AntiviralsHye Won Lee, Dai Hoon Han, Hye Jung Shin, et al.Journal of Thrombosis and Haemostasis : JTH|February 4, 2021
Safety, pharmacokinetics, and pharmacodynamics of a next-generation subcutaneously administered coagulation factor IX variant, dalcinonacog alfa, in previously treated hemophilia B patientsChur Woo You, Seung-Beom Hong, Suyeong Kim, et al.Medicine|July 30, 2016
Estimation of direct medical cost related to the management of chronic hepatitis C and its complications in South KoreaDo Young Kim, Ki Tae Yoon, Won Kim, et al.Pageof 85